Galderma, a prominent player in the skincare industry, made a remarkable debut on the SIX Swiss Exchange, with its shares soaring by 20.75 percent on the first day of trading. This surge propelled the company’s closing price well above its initial public offering (IPO) price, positioning it as one of Europe’s most successful IPOs in the current year. Notably, Galderma’s achievement marks the largest IPO placement volume in Switzerland since 2017, underscoring the heightened investor interest in the company.
The buoyancy of the global IPO market, fueled by robust equity markets and favorable interest rates, has set the stage for companies across various sectors to contemplate going public. Among these, beauty industry giants such as Spain’s Puig and Brazil’s Natura & Co. are reportedly considering similar moves. Galderma, with its illustrious history stemming from a partnership between L’Oréal and Nestlé, has emerged as a frontrunner in the skincare domain, boasting a substantial global presence.
Following its transition from Nestlé to EQT Partners and the Abu Dhabi Investment Authority, Galderma has witnessed sustained growth, expanding its operations to encompass over 90 countries. The company’s impressive sales surge in 2023 further solidifies its position in the market, indicating a promising trajectory for 2024. With a robust market performance and a promising outlook for future growth, Galderma stands poised to capitalize on its market potential and continue its upward trajectory in the skincare industry.
